3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
5
Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Colorectal Neoplasms
2
Adenocarcinoma
2
Rectal Neoplasms
1
Rectal Diseases
1
Metastatic Adenocarcinoma of the Pancreas
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colonic Neoplasms
1
Colonic Diseases
1
Adenocarcinoma Of Esophagus
1
Interventions
irinotecan sucrosofate
1
Oxaliplatin
1
Leucovorin
1
Gemcitabine
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Metastatic Adenocarcinoma of the Pancreas
×
Oxaliplatin
×
Clear all
NCT04083235
2026-04-20
NAPOLI 3
Ipsen
Phase 3
Completed
770 enrolled
13 charts
1 FDA